help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Horvath, E.
Right arrow Articles by Singer, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Horvath, E.
Right arrow Articles by Singer, W.

American Journal of Pathology, Vol 98, 617-638, Copyright © 1980 by American Society for Investigative Pathology

REGULAR ARTICLES

Silent corticotropic adenomas of the human pituitary gland: a histologic, immunocytologic, and ultrastructural study

E Horvath, K Kovacs, DW Killinger, HS Smyth, ME Platts and W Singer

Among 300 surgically removed pituitary adenomas, 17 tumors containing immunoreactive 1-39 adrenocorticotropin (ACTH) and/or 19-39 ACTH, beta- lipotropin, and alpha-endorphin but unassociated with clinical signs of Cushing's disease have been detected. These neoplasms were divided into basophilic adenomas with strong periodic acid-Schiff (PAS) and lead- hematoxylin positivity and chromophobic tumors with moderate or no PAS and lead-hematoxylin positivity. The former were densely granulated tumors with a fine structure strikingly similar to that of functioning corticotropic cell adenomas. The latter were sparsely granulated with varying ultrastructural patterns. The marked morphologic diversity suggests that these adenomas, despite their similar immunocytologic characteristics, represent more than one entity. Clinically, the most common finding was a rapidly progressing visual defect. An unusually high incidence of infarction (5 cases) and recurrence (5 cases) was noted, underlining the importance of correct morphologic diagnosis and careful follow-up.


This article has been cited by other articles:


Home page
 Eur J EndocrinolHome page
T. Tateno, H. Izumiyama, M. Doi, T. Yoshimoto, M. Shichiri, N. Inoshita, K. Oyama, S. Yamada, and Y. Hirata
Differential gene expression in ACTH -secreting and non-functioning pituitary tumors
Eur. J. Endocrinol., December 1, 2007; 157(6): 717 - 724.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
O. M. Dekkers, A. M. Pereira, F. Roelfsema, J. H. C. Voormolen, K. J. Neelis, M. A. Schroijen, J. W. A. Smit, and J. A. Romijn
Observation Alone after Transsphenoidal Surgery for Nonfunctioning Pituitary Macroadenoma
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1796 - 1801.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. A. Sakharova, E. V. Dimaraki, W. F. Chandler, and A. L. Barkan
Clinically Silent Somatotropinomas May Be Biochemically Active
J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2117 - 2121.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
U. Pagotto, G. Marsicano, F. Fezza, M. Theodoropoulou, Y. Grubler, J. Stalla, T. Arzberger, A. Milone, M. Losa, V. Di Marzo, et al.
Normal Human Pituitary Gland and Pituitary Adenomas Express Cannabinoid Receptor Type 1 and Synthesize Endogenous Cannabinoids: First Evidence for a Direct Role of Cannabinoids on Hormone Modulation at the Human Pituitary Level
J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2687 - 2696.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by the American Society for Investigative Pathology.